Quick answer: Optimal thyroid function is not “TSH within reference range” — it is TSH between 0.5–2.0 mIU/L, free T4 in the upper half of range, free T3 in the upper third of range, and negative thyroid antibodies. Subclinical hypothyroidism (TSH 4–10 mIU/L with normal free T4) affects 10–15% of adults and produces the full symptom spectrum of hypothyroidism: fatigue, weight gain, brain fog, cold intolerance, constipation, depression, and hair loss. The conventional “wait and watch” approach until TSH exceeds 10 mIU/L represents a major functional medicine gap — most symptomatic patients benefit from treatment at TSH 3–5 mIU/L with low free T3 or elevated antibodies.
Understanding Thyroid Physiology: The Complete Picture
The thyroid gland produces thyroid hormones under the control of the hypothalamic-pituitary-thyroid (HPT) axis: TRH (thyrotropin-releasing hormone) from the hypothalamus → TSH (thyroid-stimulating hormone) from the pituitary → T4 and T3 from the thyroid gland. The thyroid primarily produces T4 (approximately 80% of output) — an inactive prohormone that must be converted to T3 (the biologically active form) in peripheral tissues. This conversion occurs via deiodinase enzymes (primarily type 1 and type 2 deiodinase) in the liver, kidney, brain, and skeletal muscle. Impaired peripheral conversion — even with “normal” thyroid gland output — produces T3 deficiency with normal T4 and normal TSH: a pattern invisible to standard TSH-only screening.
The TSH limitation: TSH is a pituitary hormone that reflects the pituitary’s assessment of thyroid hormone adequacy — not the peripheral tissues’ assessment. The pituitary has its own deiodinase activity and may be adequately saturated with T3 while peripheral tissues (muscle, brain, heart) are T3-deficient. This creates the clinically common scenario of a patient with TSH of 2.5 (pituitary “happy”), low-normal free T3 (peripheral tissues unhappy), and a full complement of hypothyroid symptoms. The comprehensive thyroid panel — TSH, free T4, free T3, reverse T3, and thyroid antibodies (TPO and TG antibodies) — reveals the complete picture that TSH alone misses.
The Complete Thyroid Panel: What to Test and Why
TSH (thyroid-stimulating hormone): The pituitary signal to the thyroid. Optimal: 0.5–2.0 mIU/L. Standard reference range (0.5–4.5 mIU/L) allows TSH as high as 4.5 while considering function “normal” — but population studies show symptoms progressively worsen above TSH 2.0 mIU/L in many individuals. A TSH of 4.0 mIU/L is 8 times the pituitary signal of a TSH of 0.5 mIU/L — indicating the pituitary is working hard to maintain thyroid output. This is not “normal” with symptoms; it indicates borderline thyroid insufficiency.
Free T4 (FT4): The inactive prohormone output from the thyroid gland. Normal range varies by lab, but optimal is generally in the upper half of the reference range. Low-normal FT4 with elevated TSH confirms thyroid gland insufficiency (primary hypothyroidism). Normal FT4 with low free T3 suggests impaired T4-to-T3 conversion in peripheral tissues — the T4/T3 conversion problem.
Free T3 (FT3): The active thyroid hormone that enters cells and drives metabolism. Optimal: upper third of the reference range (typically above 3.0 pg/mL when range is 2.0–4.4 pg/mL). Low free T3 is the most directly symptom-correlated thyroid marker — symptoms of hypothyroidism correlate better with free T3 than with TSH or free T4. Low free T3 with normal TSH and normal FT4 indicates impaired peripheral conversion — the pattern requires different treatment (T3-containing preparations rather than T4-only levothyroxine).
Reverse T3 (rT3): An inactive metabolite of T4 produced when the body converts T4 away from active T3 — typically during physiological stress, caloric restriction, chronic cortisol elevation, insulin resistance, and iron deficiency. Elevated rT3 occupies T3 receptors without activating them, effectively blocking T3 action — causing cellular hypothyroidism even with normal TSH and FT4. The free T3 to reverse T3 ratio (above 20 is considered optimal) is a more sensitive marker of T3 receptor availability than either value alone.
TPO antibodies (anti-thyroid peroxidase): The primary marker for Hashimoto’s thyroiditis — an autoimmune condition in which the immune system attacks the thyroid gland. Present in 85–90% of people with Hashimoto’s thyroiditis. Elevated TPO antibodies indicate ongoing thyroid autoimmunity that will progressively destroy thyroid tissue — even before TSH becomes elevated. TPO antibodies can be positive for years to decades before standard hypothyroidism develops. Management of Hashimoto’s requires addressing the autoimmune process (gluten, selenium, vitamin D, gut barrier integrity) — not simply monitoring TSH until it rises enough to prescribe levothyroxine.
TG antibodies (anti-thyroglobulin): The second thyroid antibody marker. Present in approximately 60–70% of Hashimoto’s cases and 20–25% of Graves’ disease (autoimmune hyperthyroidism). Some patients with negative TPO antibodies have positive TG antibodies — testing both improves diagnostic sensitivity for autoimmune thyroid disease.
Factors That Impair T4-to-T3 Conversion
The deiodinase enzymes responsible for T4-to-T3 conversion require specific conditions and cofactors. Impaired conversion is extremely common — and explains why many patients on T4-only medication (levothyroxine) continue to have hypothyroid symptoms despite “normal” TSH. The factors that impair conversion:
Selenium deficiency: Type 1 and type 2 deiodinase are selenoproteins — they require selenium as a cofactor for T4-to-T3 conversion. Selenium deficiency directly impairs conversion, reducing free T3 and increasing T4 accumulation. Supplementing selenium (200 mcg of selenomethionine/day) is one of the most evidence-based thyroid interventions: it reduces TPO antibody levels by 40–50% in Hashimoto’s (via reduction of thyroid peroxidase-driven oxidative damage), improves T3 levels in people with conversion impairment, and reduces thyroid inflammation. The 2020 Cochrane review concluded selenium reduces TPO antibodies significantly with a favorable safety profile.
Iron deficiency: Iron is required for thyroid peroxidase enzyme activity (the enzyme that synthesizes T4) and for peripheral deiodinase function. Iron deficiency is the most common nutritional deficiency in women of reproductive age — and explains the female predominance of hypothyroidism symptoms in this demographic. Target ferritin above 70 ng/mL for optimal thyroid function (not just above the “normal” floor of 12–15 ng/mL). Ferritin below 30 ng/mL is strongly associated with thyroid symptoms even with normal TSH.
Zinc deficiency: Required for synthesis and receptor binding of T3. Zinc deficiency produces low T3 with elevated TSH — a pattern that resolves with zinc repletion. Zinc supplementation (30 mg zinc bisglycinate/day) improves T3 levels and reduces TSH in deficient individuals. Zinc also inhibits thyroid hormone excess (relevant in hyperthyroidism) — it modulates both ends of the spectrum.
Chronic stress and elevated cortisol: Cortisol directly inhibits T4-to-T3 conversion via suppression of deiodinase activity and upregulation of reverse T3 production. This is the biochemical explanation for hypothyroid-like symptoms in people under chronic stress — the cortisol-T3 conversion impairment produces functional cellular hypothyroidism even with normal thyroid lab values. This also explains why hypothyroid patients who are under extreme stress feel worse despite stable TSH on medication.
Low-calorie dieting: Caloric restriction is one of the most potent suppressors of T3 — a metabolic adaptation that reduces metabolic rate during food scarcity. This is a primary mechanism of diet-induced metabolic adaptation (the metabolism slowing during caloric restriction that frustrates sustained weight loss). Even modest restriction (500 kcal/day deficit) measurably reduces T3 within weeks. This is why cyclical dieting approaches, carbohydrate refeed days, and time-restricted eating rather than continuous caloric restriction are better for preserving metabolic rate.
Gut dysbiosis and leaky gut: Approximately 20% of T4-to-T3 conversion occurs in the gut (via intestinal deiodinase enzymes). Gut dysbiosis and intestinal permeability reduce this conversion, contributing to systemic T3 deficiency. This is another mechanistic connection between gut health and thyroid function — optimizing the gut microbiome is a legitimate thyroid optimization strategy.
The Thyroid Optimization Protocol
Nutritional Support for Thyroid Function
Iodine: The substrate for thyroid hormone synthesis. Iodine deficiency is the most common preventable cause of hypothyroidism globally. In developed countries with iodized salt, severe deficiency is less common, but adequate iodine (150–300 mcg/day) is essential. Important nuance: excessive iodine (above 500 mcg/day) can worsen autoimmune thyroid disease (Wolff-Chaikoff effect) — particularly in people with Hashimoto’s. Standard dietary iodine from iodized salt and seafood is appropriate; high-dose iodine supplements (kelp, Lugol’s) should be approached cautiously with Hashimoto’s.
Selenium (200 mcg/day as selenomethionine): The single most important thyroid supplement. Reduces TPO antibodies, improves T4-to-T3 conversion, and reduces thyroid inflammation via glutathione peroxidase activity (which protects thyroid cells from hydrogen peroxide-mediated oxidative damage during hormone synthesis). Brazil nuts (1–2 per day) provide approximately 150–200 mcg selenium — a food-first approach. Do not exceed 400 mcg/day total (dietary + supplemental) to avoid selenosis.
Iron (target ferritin 70–100 ng/mL): Test and replicate if ferritin is below 70 ng/mL. Iron bisglycinate or ferrous gluconate on alternate days (better tolerated than daily dosing, with comparable efficacy) for deficient individuals. Do not supplement iron without confirming deficiency — excess iron is pro-inflammatory and hepatotoxic.
Vitamin D (target 50–80 ng/mL 25(OH)D): Vitamin D receptor (VDR) activation modulates the autoimmune process in Hashimoto’s — VDR is expressed on T-regulatory cells that normally prevent autoimmunity. Vitamin D deficiency is strongly associated with autoimmune thyroid disease. Correcting deficiency is a standard component of Hashimoto’s management and may reduce antibody levels and slow autoimmune progression.
Ashwagandha (KSM-66, 300–600 mg/day): One of the few supplements with direct RCT evidence for thyroid function improvement. A 2018 Ayu Journal RCT found ashwagandha significantly increased T3 and T4 levels in subclinical hypothyroid patients compared to placebo (T3 increased by 41.5%, T4 by 19.6%). The mechanism involves ashwagandha’s reduction of cortisol (which impairs T4-to-T3 conversion) and direct thyroid stimulation via withanolides. This is particularly relevant for people with subclinical hypothyroidism and co-existing adrenal stress patterns.
Dietary Considerations
Gluten and Hashimoto’s: The relationship between gluten and Hashimoto’s is the most evidence-backed dietary connection in thyroid disease. Molecular mimicry between gliadin peptides and thyroid peroxidase protein sequences is the proposed mechanism — the immune response to gluten may cross-react with thyroid antigens in genetically susceptible individuals. Multiple studies show gluten-free diet reduces TPO and TG antibody levels in patients with both Hashimoto’s and celiac disease. For patients with positive thyroid antibodies, a 3–6 month gluten elimination trial is clinically reasonable, particularly if GI symptoms coexist.
Goitrogens — context matters: Cruciferous vegetables (broccoli, kale, Brussels sprouts), soy, millet, and cassava contain goitrogens that can impair thyroid hormone synthesis at very high raw consumption levels. The clinical significance in the context of normal dietary intake is minimal — cooking destroys most goitrogenic compounds, and the anti-cancer benefits of cruciferous vegetables outweigh any theoretical thyroid impact in people with adequate iodine intake. Concerns about goitrogens suppressing thyroid function are generally over-stated; only raw juice-cleansing quantities of raw cruciferous vegetables are likely to matter.
When to Consider Thyroid Medication
TSH above 10 mIU/L with symptoms is a standard indication for levothyroxine (T4-only). TSH 4–10 mIU/L with significant symptoms, positive antibodies, or elevated cardiovascular risk warrants a therapeutic trial of thyroid medication. The functional medicine distinction: T4-only levothyroxine does not address the T4-to-T3 conversion problem. Patients on levothyroxine who continue to have hypothyroid symptoms with normal TSH and normal free T4 but low free T3 typically require a combination T4/T3 preparation (like desiccated thyroid extract — Armour Thyroid, NP Thyroid) or a small dose of liothyronine (synthetic T3) added to levothyroxine. This requires a physician who specializes in thyroid management beyond TSH normalization.
The Bottom Line
Thyroid optimization requires a complete panel (TSH, free T4, free T3, reverse T3, TPO and TG antibodies), interpretation against functional reference ranges (not just standard lab ranges), and addressing the multiple factors that impair T4-to-T3 conversion before assuming medication is the only solution. Selenium, iron, zinc, vitamin D, cortisol management, and gut microbiome optimization are all evidence-based levers that improve thyroid function measurably. When medication is needed, ensuring that T3 levels — not just TSH — are optimized is essential to resolving symptoms rather than normalizing a number while the patient continues to feel unwell.
If you have been told your thyroid is “normal” but continue to experience fatigue, weight gain, brain fog, cold intolerance, constipation, or depression, requesting a complete thyroid panel including free T3, reverse T3, and thyroid antibodies is the appropriate next step. Call our office at (810) 206-1402 for a functional medicine evaluation that goes beyond TSH to identify and address the root cause of your thyroid symptoms.
Frequently Asked Questions
What is the optimal TSH level?
The functional medicine optimal range for TSH is 0.5–2.0 mIU/L — substantially narrower than the standard reference range of 0.5–4.5 mIU/L. A TSH of 4.0 mIU/L indicates the pituitary is working 8 times harder than at TSH 0.5 to maintain thyroid output — that is not “normal,” it indicates the thyroid is straining to meet demand. Symptomatic patients with TSH above 2.0 mIU/L and low free T3 have hypothyroid-range physiology despite being within the conventional reference range.
Can you have hypothyroid symptoms with normal TSH?
Yes — and this is common. If free T3 is low-normal despite normal TSH and free T4, impaired T4-to-T3 conversion is causing cellular hypothyroidism. This pattern is found in people with selenium or iron deficiency, chronic stress (elevated cortisol impairs conversion), caloric restriction, gut dysbiosis, and certain genetic variants in deiodinase enzymes. Standard TSH-only screening completely misses this pattern. A full thyroid panel is required to identify it.
What are the best supplements for thyroid health?
Evidence-ranked: (1) Selenium (200 mcg selenomethionine/day) — reduces TPO antibodies 40-50% and improves T4-to-T3 conversion; (2) Iron (to ferritin 70-100 ng/mL) — required for thyroid peroxidase and deiodinase function; (3) Vitamin D (to 50-80 ng/mL) — modulates autoimmune thyroid disease; (4) Zinc (30 mg/day) — required for T3 receptor binding and synthesis; (5) Ashwagandha KSM-66 (300-600 mg/day) — shown in RCT to raise T3 and T4 in subclinical hypothyroid patients.
Is Hashimoto’s thyroiditis the most common cause of hypothyroidism?
Yes — Hashimoto’s thyroiditis (autoimmune thyroid disease) is the most common cause of hypothyroidism in iodine-sufficient countries, accounting for 90-95% of primary hypothyroidism in the US. It is characterized by positive TPO and/or TG antibodies, lymphocytic infiltration of the thyroid gland, and progressive destruction of thyroid tissue. The conventional treatment focuses on hormone replacement as the gland fails, but functional medicine addresses the autoimmune process itself (selenium, vitamin D, gluten elimination, gut barrier integrity) to slow antibody progression and preserve thyroid tissue.
Dive Deeper
- Hashimoto’s Thyroiditis: The Autoimmune Root Causes and the Protocol
- Estrogen Dominance: Symptoms, Causes, and the Treatment Protocol
- What Your Vitamin D Level Actually Means (And Why 30 ng/mL Is Not Enough)
- Magnesium Deficiency: The Most Overlooked Reason You Feel Terrible
- Insulin Resistance: Why 40% of Adults Have It and Don’t Know It